Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design. Allen AM, Therneau TM, Ahmed OT, Gidener T, et al. J Hepatol 2022;77:1237-1245.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Allen AM, Therneau TM, Ahmed OT, Gidener T, et al. Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design. J Hepatol 2022;77:1237-1245.
PMID: 35843374